
bioentrepreneur. From bench to boardroom
The twain shall meet http://www.nature.com/nbt/journal/v27/n1 0/index.html
www.nature.com
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

bioentrepreneur. From bench to boardroom Credibility, your most important asset
www.nature.com
The Bioentrepreneur portal has evolved from a series of supplements published by Nature Biotechnology since 1998. Its mission is to become an interactive online resource for researchers hoping to commercialize their research, and for those working for and with young life science companies. ...

bioentrepreneur. From bench to boardroom DNA confidential
www.nature.com
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

bioentrepreneur. From bench to boardroom Nature Network
network.nature.com
Connecting scientists worldwide, with blogs, forums, and groups. Social networking for scientists. From the publishers of Nature.

bioentrepreneur. From bench to boardroom A blueprint for biotech's blues
www.nature.com
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

bioentrepreneur. From bench to boardroom Business plan competitions (BPCs)
www.nature.com
The Bioentrepreneur portal has evolved from a series of supplements published by Nature Biotechnology since 1998. Its mission is to become an interactive online resource for researchers hoping to commercialize their research, and for those working for and with young life science companies. ...

bioentrepreneur. From bench to boardroom credit where credit is overdue
www.nature.com
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

bioentrepreneur. From bench to boardroom US - Healthcare Reform 2009
online.wsj.com
The drug industry, already the biggest-spending lobby in Washington, is placing an even bigger bet on the influence game.

bioentrepreneur. From bench to boardroom Nearly 11 years after Wisconsin-led researchers reported the first isolation of human embryonic stem cells, the field became eligible this week for broad research funding by the US government.
www.nature.com
Nature - the world's best science and medicine on your desktop

bioentrepreneur. From bench to boardroom For entrepreneurs developing innovative technology, the platform business model is making a comeback.
www.nature.com
The Bioentrepreneur portal has evolved from a series of supplements published by Nature Biotechnology since 1998. Its mission is to become an interactive online resource for researchers hoping to commercialize their research, and for those working for and with young life science companies. ...

bioentrepreneur. From bench to boardroom
http://www.nytimes.com/2009/06/28/health /research/28cancer.html?_r=1&ref=researc h
www.nytimes.com
A major impediment in the fight against cancer is that most research grants go to projects unlikely to break much ground.

www.scibx.com
Researchers at the Burnham Institute for Medical Research and the Dana-Farber Cancer Institute have independently identified peptides that modulate mitochondrial apoptosis and may have promise in cancer. ...

www.nature.com
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, ...

bioentrepreneur. From bench to boardroom
http://www.nature.com/bioent/2008/081201 /full/bioe.2008.12.html
www.nature.com
The Bioentrepreneur portal has evolved from a series of supplements published by Nature Biotechnology since 1998. Its mission is to become an interactive online resource for researchers hoping to commercialize their research, and for those working for and with young life science companies. ...



























